{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:58:36Z","timestamp":1760061516657,"version":"3.38.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"DOI":"10.2146\/ajhp100159","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T21:45:07Z","timestamp":1303508707000},"page":"814-817","source":"Crossref","is-referenced-by-count":3,"title":["Moxifloxacin\u2013acetaminophen\u2013warfarin interaction during bacille Calmette-Gu\u00e9rin treatment for bladder cancer"],"prefix":"10.1093","volume":"68","author":[{"given":"Roy","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Wen","sequence":"additional","affiliation":[{"name":"Oral Anticoagulation Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Berube","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology, Stanford Hospital and Clinics, Palo Alto, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"(suppl 1)","key":"key\n\t\t\t\t2019041105532588200_b1-0680814","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000052381","article-title":"BCG intravesical instillations: recommendations for side-effects management","volume":"37","author":"Rischmann","year":"2000","journal-title":"Eur Urol."},{"key":"key\n\t\t\t\t2019041105532588200_b2-0680814","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.juro.2006.04.104","article-title":"The effect of ofloxacin on bacillus Calmette-Guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study","volume":"176","author":"Colombel","year":"2006","journal-title":"J Urol."},{"volume-title":"Coumadin (warfarin) package insert","year":"2010","key":"key\n\t\t\t\t2019041105532588200_b3-0680814"},{"key":"key\n\t\t\t\t2019041105532588200_b4-0680814","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA."},{"key":"key\n\t\t\t\t2019041105532588200_b5-0680814","first-page":"1621","article-title":"Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study","volume":"91","author":"Mah\u00e9","year":"2006","journal-title":"Haematologica."},{"key":"key\n\t\t\t\t2019041105532588200_b6-0680814","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2125.2004.02199.x","article-title":"Paracetamol: a haemorrhagic risk factor in patients on warfarin","volume":"59","author":"Mah\u00e9","year":"2005","journal-title":"Br J Clin Pharmacol."},{"key":"key\n\t\t\t\t2019041105532588200_b7-0680814","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1592\/phco.27.5.675","article-title":"The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy","volume":"27","author":"Parra","year":"2007","journal-title":"Pharmacotherapy."},{"key":"key\n\t\t\t\t2019041105532588200_b8-0680814","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jamda.2007.06.013","article-title":"Potentially lethal acetaminophen-warfarin interaction in an older adult: an under-recognized phenomenon?","volume":"8","author":"Dharmarajan","year":"2007","journal-title":"J Am Med Dir Assoc."},{"key":"key\n\t\t\t\t2019041105532588200_b9-0680814","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3949\/ccjm.71.8.651","article-title":"A 76-year-old woman with erratic anticoagulation","volume":"71","author":"Lesho","year":"2004","journal-title":"Cleve Clin J Med."},{"key":"key\n\t\t\t\t2019041105532588200_b10-0680814","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1592\/phco.2005.25.6.904","article-title":"Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction","volume":"25","author":"Arnold","year":"2005","journal-title":"Pharmacotherapy."},{"key":"key\n\t\t\t\t2019041105532588200_b11-0680814","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0953-6205(03)00067-0","article-title":"The interaction of moxifloxacin and warfarin in three elderly patients","volume":"14","author":"O\u2019Connor","year":"2003","journal-title":"Eur J Intern Med."},{"key":"key\n\t\t\t\t2019041105532588200_b12-0680814","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1345\/aph.1E179","article-title":"Moxifloxacin-warfarin interaction: a series of five case reports","volume":"39","author":"Elbe","year":"2005","journal-title":"Ann Pharmacother."},{"key":"key\n\t\t\t\t2019041105532588200_b13-0680814","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00380-008-1050-0","article-title":"A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve","volume":"23","author":"Yildiz","year":"2008","journal-title":"Heart Vessels."},{"key":"key\n\t\t\t\t2019041105532588200_b14-0680814","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy\u2014who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thromb Haemost."},{"key":"key\n\t\t\t\t2019041105532588200_b15-0680814","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","article-title":"Acetaminophen and other risk factors for excessive warfarin anticoagulation","volume":"279","author":"Hylek","year":"1998","journal-title":"JAMA."},{"key":"key\n\t\t\t\t2019041105532588200_b16-0680814","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1160\/TH04-02-0109","article-title":"Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle","volume":"92","author":"Thijssen","year":"2004","journal-title":"Thromb Haemost."},{"volume-title":"Avelox (moxifloxacin) package insert","year":"2008","key":"key\n\t\t\t\t2019041105532588200_b17-0680814"},{"key":"key\n\t\t\t\t2019041105532588200_b18-0680814","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-9556(25)08417-X","article-title":"Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human","volume":"24","author":"Mc Lellan","year":"1996","journal-title":"Drug Metab Dispos."},{"key":"key\n\t\t\t\t2019041105532588200_b19-0680814","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/9\/814\/28349401\/ajhp0814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T06:19:24Z","timestamp":1741155564000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/9\/814\/5129746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,1]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100159","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"type":"print","value":"1079-2082"},{"type":"electronic","value":"1535-2900"}],"subject":[],"published-other":{"date-parts":[[2011,5,1]]},"published":{"date-parts":[[2011,5,1]]}}}